This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2007 by Sheba Medical Center.
Recruitment status was:  Recruiting
Information provided by:
Sheba Medical Center Identifier:
First received: January 23, 2007
Last updated: February 18, 2007
Last verified: February 2007
Study comparing level of free radicals in tumor tissue, blood serum and saliva in patients with Squamous Cell Carcinoma of tongue and mouth floor. Patients with benign fibroma of oral cavity and normal gingiva around extracted lower wisdom tooth are used for control

Condition Phase
Squamous Cell Carcinoma Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Sheba Medical Center:


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  1. Older than 18 years of age.
  2. Mentally healthy
  3. SCC of Tongue or Mouth Floor
  4. Benign Fibroma of Oral Cavity
  5. Lower wisdom tooth extraction -

Exclusion Criteria:

  1. Younger than 18 years of age
  2. Mentally incapacitated
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00426062

Contact: Alex Dobriyan, DMD 972-3-6040306
Contact: Ran Yahalom, DMD 972-3-5303819

Sheba Medical Center Recruiting
Ramat Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Alex Dobriyan, DMD Sheba Medical Center
Principal Investigator: Ran Yahalom, DMD Sheba Medical Center
Principal Investigator: Rafi Nagler, DMD,MD Rambam Health Care Campus
  More Information Identifier: NCT00426062     History of Changes
Other Study ID Numbers: SHEBA-06-4116-AD-CTIL
Study First Received: January 23, 2007
Last Updated: February 18, 2007

Keywords provided by Sheba Medical Center:
Squamous Cell Carcinoma of Tongue and mouth floor

Additional relevant MeSH terms:
Carcinoma, Squamous Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Squamous Cell processed this record on August 18, 2017